Sb Management Ltd 13F annual report

Sb Management Ltd is an investment fund managing more than $945 million ran by Akshay Naheta. There are currently 19 companies in Naheta’s portfolio. The largest investments include Pacific Biosciences Calif In and AbCellera Biologics, together worth $405 million.

$945 million Assets Under Management (AUM)

As of 5th November 2021, Sb Management Ltd’s top holding is 8,156,107 shares of Pacific Biosciences Calif In currently worth over $208 million and making up 22.0% of the portfolio value. In addition, the fund holds 9,817,190 shares of AbCellera Biologics worth $197 million, whose value fell 52.1% in the past six months. The third-largest holding is Sema4 Holdings Corp worth $68.5 million and the next is Lyell Immunopharma Inc worth $51.8 million, with 3,500,000 shares owned.

Currently, Sb Management Ltd's portfolio is worth at least $945 million. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.

Careers at Sb Management Ltd

The Sb Management Ltd office and employees reside in Abu Dhabi, United Arab Emirates. According to the last 13-F report filed with the SEC, Akshay Naheta serves as the CEO at Sb Management Ltd.

Recent trades

In the most recent 13F filing, Sb Management Ltd revealed that it had opened a new position in Sema4 Holdings Corp and bought 9,021,524 shares worth $68.5 million.

The investment fund also strengthened its position in AbCellera Biologics by buying 2,000,000 additional shares. This makes their stake in AbCellera Biologics total 9,817,190 shares worth $197 million. AbCellera Biologics dropped approximately 0.1% in the past year.

On the other hand, there are companies that Sb Management Ltd is getting rid of from its portfolio. Sb Management Ltd closed its position in Amazon.com on 12th November 2021. It sold the previously owned 2,007,382 shares for $6.21 billion. Akshay Naheta also disclosed a decreased stake in Pacific Biosciences Calif In by 0.2%. This leaves the value of the investment at $208 million and 8,156,107 shares.

One of the average hedge funds

The two most similar investment funds to Sb Management Ltd are Summit Creek Advisors and Baystate Wealth Management. They manage $946 million and $944 million respectively.


Akshay Naheta investment strategy

Sb Management Ltd’s portfolio is diversified across 2 sectors. Currently, their heaviest sector is Health Care — making up 20.8% of the total portfolio value. The fund focuses on investments in the Canada as 5.3% of the portfolio companies are based in the Canada.

The majority of the companies in the fund’s portfolio are large-cap stocks. Stocks with a size of more than $10 billion in market cap make up approximately 0.1% of the total holdings value. On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio. The average market cap of the portfolio companies is close to $4.08 billion.

The complete list of Sb Management Ltd trades based on 13F SEC filings

These positions were updated on November 12th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.

Security Shares Owned Value Allocation
Amazon.com Inc.
Closed
2,007,382
$6,211,000,000
Meta Platforms Inc
Closed
10,802,959
$3,181,796,000
Taiwan Semiconductor Mfg Ltd
Closed
11,163,862
$1,320,462,000
PayPal Holdings Inc
Closed
4,859,413
$1,180,060,000
Microsoft Corporation
Closed
4,368,656
$1,029,998,000
Alphabet Inc
Closed
277,750
$574,562,000
Salesforce.Com Inc
Closed
1,816,709
$384,906,000
NetFlix Inc
Closed
731,375
$381,529,000
Pacific Biosciences Calif In
17.29%
8,156,107
$208,389,000 22.05%
AbCellera Biologics Inc.
25.58%
9,817,190
$196,736,000 20.82%
Sema4 Holdings Corp
Opened
9,021,524
$68,473,000 7.25%
Lyell Immunopharma Inc
Opened
3,500,000
$51,800,000 5.48%
Cm Life Sciences Inc
Closed
3,379,704
$50,324,000
Sana Biotechnology Inc
15.85%
2,209,004
$49,747,000 5.26%
Ftac Hera Acquisition Corp
Opened
5,000,000
$48,700,000 5.15%
Elliott Opportunity Ii Corp
Opened
4,950,000
$48,213,000 5.10%
Khosla Ventures Acqut Co Iii
14.29%
4,000,000
$39,200,000 4.15%
Compute Health Acquisitin Co
Opened
4,000,000
$39,080,000 4.14%
Khosla Ventures Acqustn Co I
Closed
3,000,000
$30,270,000
Revolution Healthcar Aq Corp
Opened
3,000,000
$29,130,000 3.08%
Somalogic Inc
Opened
2,200,000
$27,258,000 2.88%
Aurora Acquisition Corp
Opened
2,700,000
$26,811,000 2.84%
Pioneer Merger Corp.
Closed
2,750,000
$26,730,000
Thoma Bravo Advantage
Closed
2,500,000
$26,125,000
Montes Archimedes Acquisitio
Opened
2,500,000
$23,375,000 2.47%
Doma Holdings Inc
Opened
2,671,401
$19,768,000 2.09%
Svf Investment Corp 3
No change
2,000,000
$19,660,000 2.08%
Cm Life Sciences Iii Inc
Opened
1,926,600
$19,112,000 2.02%
4d Molecular Therapeutics In
Closed
347,910
$15,092,000
Khosla Ventures Acquisition
Closed
1,000,000
$10,100,000
Arqit Quantum Inc
Opened
500,000
$10,035,000 1.06%
Svf Investment Corp 2
No change
1,000,000
$9,820,000 1.04%
Blue Whale Acquisition Corp
Opened
998,000
$9,775,000 1.03%
Adobe Systems Incorporated
Closed
20,048
$9,530,000
Bridgetown 2 Holdings Ltd
Closed
500,000
$5,120,000
No transactions found
Showing first 500 out of 35 holdings